A correlate of protection for SARS-CoV-2 vaccines is urgently needed

Nat Med. 2021 Jul;27(7):1147-1148. doi: 10.1038/s41591-021-01432-4.

Author

Florian Krammer^{1

2}

Affiliations

¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.
² Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.

PMID: 34239135
DOI: 10.1038/s41591-021-01432-4

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Viral
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Viral Vaccines*

Substances

Antibodies, Viral
COVID-19 Vaccines
Viral Vaccines

Grants and funding